These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19396327)

  • 1. [Membranoproliferative glomerulonephritis and monoclonal gammopathy of uncertain significance].
    Villacorta J; Saiz A; Quereda C; Ortuño J
    Nefrologia; 2009; 29(2):175-6. PubMed ID: 19396327
    [No Abstract]   [Full Text] [Related]  

  • 2. Membranoproliferative glomerulonephritis type II (dense deposit disease) in association with monoclonal gammopathy.
    Hill PA; Desmond M
    Nephrology (Carlton); 2007 Aug; 12(4):419-20. PubMed ID: 17635761
    [No Abstract]   [Full Text] [Related]  

  • 3. Membranoproliferative glomerulonephritis associated with IgA-λ monoclonal gammopathy.
    Wu B; Chen P; Wang W; Li F; Zou S; Cheng Y
    Ann Hematol; 2014 Feb; 93(2):359-60. PubMed ID: 23778994
    [No Abstract]   [Full Text] [Related]  

  • 4. A Patient with Abnormal Kidney Function and a Monoclonal Light Chain in the Urine.
    Leung N; Nasr SH
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):1073-1082. PubMed ID: 26992418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal gammopathy of renal significance and membranoproliferative glomerulonephritis: a complex relationship with promising therapeutic opportunities].
    Manes M; Radin E; Pellu' V; Molino A A; Gabrielli D; Parodi E; Caputo D; Paternoster G; Barreca A; Pagliaro M; Quattrocchio G; Roccatello D
    G Ital Nefrol; 2019 Jul; 36(4):. PubMed ID: 31373468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent membranoproliferative glomerulonephritis in a renal transplant secondary to monoclonal gammopathy of renal significance successfully treated with bortezomib.
    Chow KL; Kanellis J; Dayan S; Ryan J
    Intern Med J; 2019 Jun; 49(6):801-802. PubMed ID: 31185533
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Monoclonal Gammopathy-associated C3 Glomerulopathy With Daratumumab-based Therapy.
    Coltoff A; Bomback A; Shirazian S; Lentzsch S; Bhutani D
    Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e674-e677. PubMed ID: 34023209
    [No Abstract]   [Full Text] [Related]  

  • 8. Rare Case of C3 Glomerulopathy in a Patient of Type 1 Diabetes Mellitus.
    Godara S; Saraf KK
    Saudi J Kidney Dis Transpl; 2022 Feb; 33(Supplement):S83-S86. PubMed ID: 37102528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.
    Alonso-Titos J; Perea-Ortega L; Sola E; Torres-Rueda A; León M; Toledo R; Duarte AD; Vazquez T; Martinez-Esteban MD; Bailen A; Ruiz-Esteban P; Hernandez D
    BMC Nephrol; 2018 Jun; 19(1):129. PubMed ID: 29884135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal cryoglobulinemia in hepatitis C virus-associated, membranoproliferative glomerulonephritis.
    Montagna G; Piazza V; Salvadeo A
    Am J Kidney Dis; 2003 Aug; 42(2):430. PubMed ID: 12900834
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrence of light-chain deposition disease after renal transplantation.
    Larsen T; Hammer A; Jørgensen KA
    Scand J Urol Nephrol; 2008; 42(2):187-8. PubMed ID: 17853051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
    Sethi S; Sukov WR; Zhang Y; Fervenza FC; Lager DJ; Miller DV; Cornell LD; Krishnan SG; Smith RJ
    Am J Kidney Dis; 2010 Nov; 56(5):977-82. PubMed ID: 20832153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dense deposit disease in association with monoclonal gammopathy of unknown significance.
    Sepandj F; Trillo A
    Nephrol Dial Transplant; 1996 Nov; 11(11):2309-12. PubMed ID: 8941598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid therapy alone for the treatment of C3 glomerulonephritis in association with monoclonal gammopathy
.
    Sathick IJ; Zand L; Nasr SH; Leung N
    Clin Nephrol; 2019 Feb; 91(2):79-86. PubMed ID: 30474593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal-storing histiocytosis.
    Shah S; Sethi S; Arend L; Geetha D
    Kidney Int; 2016 Feb; 89(2):507. PubMed ID: 26806837
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extracapillary proliferative glomerulonephritis in relapsing polychondritis].
    Falguera M; Clotet J; Mardarás J; Panadés MJ; Ruiz F; Rubio-Caballero M
    Med Clin (Barc); 1988 Oct; 91(13):502-4. PubMed ID: 3226202
    [No Abstract]   [Full Text] [Related]  

  • 17. Membranoproliferative glomerulonephritis in a patient with common variable hypogammaglobulinemia.
    Ohkubo H; Nagai M; Hojo S; Daikuhara H; Takahara J; Itoh T; Harada A
    J Rheumatol; 1993 May; 20(5):918-9. PubMed ID: 8336329
    [No Abstract]   [Full Text] [Related]  

  • 18. Intracapillary proliferative glomerulonephritis due to heavy chain deposition disease.
    Vedder AC; Weening JJ; Krediet RT
    Nephrol Dial Transplant; 2004 May; 19(5):1302-4. PubMed ID: 15102968
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal lymphomatous infiltration in patient with nefrotic syndrome.
    Merino García E; Pérez Del Barrio MP; Borrego Hinojosa J; Borrego Utiel FJ; Sánchez Perales MC
    Nefrologia (Engl Ed); 2018; 38(1):92-94. PubMed ID: 29066117
    [No Abstract]   [Full Text] [Related]  

  • 20. Mannose-binding lectin contributes to glomerulonephritis induced by hepatitis C virus infection.
    Endo M; Ohsawa I; Ohi H; Fujita T; Matsushita M; Fujita T
    Nephron; 2001 Apr; 87(4):374-5. PubMed ID: 11287785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.